Journal of Neuroscience 2013-12-04

Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.

Eric J Nunes, Patrick A Randall, Evan E Hart, Charlotte Freeland, Samantha E Yohn, Younis Baqi, Christa E Müller, Laura López-Cruz, Mercè Correa, John D Salamone

Index: J. Neurosci. 33(49) , 19120-30, (2013)

Full Text: HTML

Abstract

Motivated behaviors are often characterized by a high degree of behavioral activation, and work output and organisms frequently make effort-related decisions based upon cost/benefit analyses. Moreover, people with major depression and other disorders often show effort-related motivational symptoms such as anergia, psychomotor retardation, and fatigue. It has been suggested that tasks measuring effort-related choice behavior could be used as animal models of the motivational symptoms of depression, and the present studies characterized the effort-related effects of the vesicular monoamine transport (VMAT) inhibitor tetrabenazine. Tetrabenazine produces depressive symptoms in humans and, because of its selective inhibition of VMAT-2, it preferentially depletes dopamine (DA). Rats were assessed using a concurrent fixed-ratio 5/chow feeding choice task that is known to be sensitive to dopaminergic manipulations. Tetrabenazine shifted response choice in rats, producing a dose-related decrease in lever pressing and a concomitant increase in chow intake. However, it did not alter food intake or preference in parallel free-feeding choice studies. The effects of tetrabenazine on effort-related choice were reversed by the adenosine A2A antagonist MSX-3 and the antidepressant bupropion. A behaviorally active dose of tetrabenazine decreased extracellular DA in nucleus accumbens and increased expression of DARPP-32 in accumbens medium spiny neurons in a pattern indicative of reduced transmission at both D1 and D2 DA receptors. These experiments demonstrate that tetrabenazine, which is used in animal models to produce depression-like effects, can alter effort-related choice behavior. These studies have implications for the development of animal models of the motivational symptoms of depression and related disorders.


Related Compounds

  • Dopamine hydrochlo...
  • Tetrabenazine
  • bupropion hydrochl...

Related Articles:

'Dopamine-first' mechanism enables the rational engineering of the norcoclaurine synthase aldehyde activity profile.

2015-03-01

[FEBS J. 282(6) , 1137-51, (2015)]

Permeation of Dopamine Sulfate through the Blood-Brain Barrier.

2015-01-01

[PLoS ONE 10 , e0133904, (2015)]

Increasing the Collision Rate of Particle Impact Electroanalysis with Magnetically Guided Pt-Decorated Iron Oxide Nanoparticles.

2015-07-28

[ACS Nano 9 , 7583-95, (2015)]

Force nanoscopy of hydrophobic interactions in the fungal pathogen Candida glabrata.

2015-02-24

[ACS Nano 9(2) , 1648-55, (2015)]

A simple method for patterning poly(dimethylsiloxane) barriers in paper using contact-printing with low-cost rubber stamps.

2015-02-09

[Anal. Chim. Acta 858 , 82-90, (2015)]

More Articles...